Submit Deal

Y-MABS THERAPEUTICS INC

HQ - New York

Summary

Y-mAbs Therapeutics is a biopharmaceutical company that focuses on the development and commercialization of novel antibody-based therapeutic products for the treatment of various cancer indications.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 310 M

Avg. Deal Size£ 310 M

Market Context

Senior Management

Michael Rossi
CEO and a Member of the Board of Directors

Sort

05 Aug 2025|United States|Biotechnology

Target: Y-MABS THERAPEUTICS INC

Bidder: SERB PHARMACEUTICALS

8 Service Providers

4 Target | 4 Bidder

7 Dealmakers

4 Target | 3 Bidder

£ 309 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy